Elevance Health (ELV) 8-K Current Report: March 10, 2026
Filed: March 10, 2026
Financials
Hospital & Medical Service PlansElevance Health (ELV) 8-K current report filed with SEC EDGAR on March 10, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 7.01: Regulation FD Disclosure
Elevance Health 8-K Mar 10, 2026 Event Analysis
Item 7.01 · Regulation FD Disclosure
- • ELV reaffirms 2026 adjusted EPS guidance of at least $25.50 per diluted share, already factoring in potential CMS Medicare Advantage enrollment sanctions
- • 2026 benefit expense ratio guidance reaffirmed at 90.2% ±50 bps — a high ratio signaling continued cost pressure in the medical segment
- • CMS sanctions (effective March 31, 2026) suspend new Medicare Advantage-PD enrollment and certain beneficiary communications — material top-line risk to Medicare growth
- • Company cannot reconcile adjusted to GAAP EPS "without unreasonable effort" — signals potential material financial payments to resolve CMS matter remain unquantified
Other Elevance Health 8-K Filings
Get deeper insights on Elevance Health
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.